photosensitivity, atopic dermatitis, infantile xerotic eczema, infantile eczema
Conditions
Interventions
The study doctor selects the test product to be used from among the test samples (six types of sunscreen agents) based on the required level of light-blocking effectiveness and the action wavelength (
Sponsors
Takano Medical Clinic
New Takano Medical Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Children diagnosed with photosensitivity, atopic dermatitis, infantile xerotic eczema, or infantile eczema, for whom the use of this investigational drug is deemed therapeutically beneficial, and their parents.
Exclusion criteria
Exclusion criteria: (I)Individuals with a history of severe skin reactions caused by sunscreen use (II)Individuals with rashes or other conditions on the application site that make application of the test product inappropriate (III)Cases where interference between the test product and other topical treatments is anticipated (IV)Individuals who, in principle, cannot attend a follow-up examination 2 weeks later or at the end of the trial (4 weeks later) (V)Individuals deemed unsuitable for participation in this study by the study physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study doctor will conduct examinations at the start ,after two weeks, and at the end of the trial (4 weeks later), including assessment of skin findings, photography, and questionnaire surveys. | — |
Countries
Japan
Contacts
Public ContactYUMI MURAKAMI
TOKIWA Pharmaceutical Co., Ltd. NOV Academic Research
Outcome results
None listed